Search Results - "Vicente Tavares, Angela Maria"
-
1
Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice
Published in Gene therapy (01-02-2020)“…Mucopolysaccharidosis type I (MPS I) is caused by deficiency of alpha-L-iduronidase (IDUA), leading to multisystemic accumulation of glycosaminoglycans (GAG)…”
Get full text
Journal Article -
2
Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice
Published in Life sciences (1973) (01-03-2018)“…Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder with multisystemic features, including heart enlargement, heart valve dysfunction, and…”
Get full text
Journal Article -
3
Chronic whole-body heat treatment relieves atherosclerotic lesions, cardiovascular and metabolic abnormalities, and enhances survival time restoring the anti-inflammatory and anti-senescent heat shock response in mice
Published in Biochimie (01-01-2019)“…Unhealthy lifestyle persistently feeds forward inflammation in metabolic organs thus imposing senescence-associated secretory phenotype (SASP), as observed in…”
Get full text
Journal Article -
4
Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I
Published in Journal of inherited metabolic disease (01-05-2017)Get full text
Journal Article -
5
Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I
Published in PloS one (03-02-2015)“…Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of α-L-iduronidase (IDUA), which leads to storage of heparan and dermatan…”
Get full text
Journal Article -
6
Effects of diaphragmatic contraction on lower limb venous return and central hemodynamic parameters contrasting healthy subjects versus heart failure patients at rest and during exercise
Published in Physiological reports (01-12-2014)“…The main objective was to assess the effects of abdominal breathing (AB) versus subject's own breathing on femoral venous blood flow (Qfv) and their…”
Get full text
Journal Article -
7
Redox-sensitive prosurvival and proapoptotic protein expression in the myocardial remodeling post-infarction in rats
Published in Molecular and cellular biochemistry (01-08-2010)“…In this study, we investigated the oxidative stress influence in some prosurvival and proapoptotic proteins after myocardial infarction (MI). Male Wistar rats…”
Get full text
Journal Article -
8
In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
Published in Journal of controlled release (28-10-2018)“…Mucopolysaccharidosis type I (MPS I) is a multisystemic disorder caused by the deficiency of alpha-L-iduronidase (IDUA) that leads to intracellular…”
Get full text
Journal Article -
9
Characterization of heart disease in mucopolysaccharidosis type II mice
Published in Cardiovascular pathology (01-11-2023)“…•Mucopolysaccharidosis type II leads to progressive loss of cardiac function.•Iduronate-2-sulfatase enzyme deficiency causes damage to the cardiovascular…”
Get full text
Journal Article -
10
Effects of Copaiba Oil in Peripheral Markers of Oxidative Stress in a Model of Cor Pulmonale in Rats
Published in Arquivos brasileiros de cardiologia (01-12-2021)“…To date, copaiba oil's systemic effects have never documented in Cor pulmonale induced by monocrotaline. To investigate copaiba oil's effects in peripheral…”
Get full text
Journal Article -
11
Cardiac pathology in mucopolysaccharidosis I mice: Losartan modifies ERK1/2 activation during cardiac remodeling
Published in Journal of inherited metabolic disease (01-05-2021)“…Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder caused by mutations in the IDUA gene, that codifies the alpha‐L‐iduronidase enzyme, which…”
Get full text
Journal Article -
12
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity
Published in Cardiovascular pathology (01-03-2017)“…Abstract Mucopolysaccharidosis type I (MPS I) is a lysosomal disorder characterized by a deficiency of alpha-L-iduronidase and storage of undegraded…”
Get full text
Journal Article -
13
Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats
Published in Journal of cardiovascular pharmacology (01-11-2018)“…There is an increase in oxidative stress and apoptosis signaling during the transition from hypertrophy to right ventricular (RV) failure caused by pulmonary…”
Get full text
Journal Article -
14
Aerobic Exercise Promotes a Decrease in Right Ventricle Apoptotic Proteins in Experimental Cor Pulmonale
Published in Journal of cardiovascular pharmacology (01-09-2015)“…Pulmonary arterial hypertension is characterized by progressive increases in resistance and pressure in the pulmonary artery and Cor pulmonale. The effect of…”
Get full text
Journal Article -
15
Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial hypertension
Published in Journal of cardiovascular pharmacology (01-02-2017)“…ABSTRACTCopaiba oil comes from an Amazonian tree and has been used as an alternative medicine in Brazil. However, it has not been investigated yet in the…”
Get full text
Journal Article -
16
Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction
Published in Life sciences (1973) (18-12-2010)“…Bone marrow cell (BMC) therapy is thought to exert beneficial effects on the infarcted heart. We assessed cardiac function and its correlation with redox…”
Get full text
Journal Article -
17
Atorvastatin administered before myocardial infarction in rats improves contractility irrespective of metabolic changes
Published in Clinical and experimental pharmacology & physiology (01-12-2014)“…Summary Statins have a beneficial effect after myocardial infarction, but the relationship between glucose transporters and their use before the event has not…”
Get full text
Journal Article -
18
Deleterious effects of interruption followed by reintroduction of enzyme replacement therapy on a lysosomal storage disorder
Published in Translational research : the journal of laboratory and clinical medicine (01-10-2016)“…Abstract Temporary interruption of enzyme replacement therapy (ERT) in patients with different lysosomal storage disorders (LSD) may happen for different…”
Get full text
Journal Article -
19
Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha- l -iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice
Published in Cytotherapy (Oxford, England) (01-08-2012)“…Abstract Background aims Mucopolysaccharidosis type I (MPS I) is characterized by deficiency of the enzyme alpha- l -iduronidase (IDUA) and storage of…”
Get full text
Journal Article -
20
Time course of hydrogen peroxide–thioredoxin balance and its influence on the intracellular signalling in myocardial infarction
Published in Experimental physiology (01-06-2012)“…We investigated the myocardial thioredoxin‐1 and hydrogen peroxide concentrations and their association with some prosurvival and pro‐apoptotic proteins,…”
Get full text
Journal Article